Objective: To identify existing prediction models for the risk of development of type 2 diabetes and to externally validate them in a large independent cohort. Data sources: Systematic search of English, German, and Dutch literature in PubMed until February 2011 to identify prediction models for diabetes. Design: Performance of the models was assessed in terms of discrimination (C statistic) and calibration (calibration plots and Hosmer-Lemeshow test).The validation study was a prospective cohort study, with a case cohort study in a random subcohort. Setting: Models were applied to the Dutch cohort of the European Prospective Investigation into Cancer and Nutrition cohort study (EPIC-NL). Participants: 38 379 people aged 20-70 with no diabe...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
BACKGROUND: The World Health Organisation estimates that by 2030 there will be approximately 350 mil...
Aims: to identify all cardiovascular disease risk prediction models developed in patients with type ...
OBJECTIVE: To identify existing prediction models for the risk of development of type 2 diabetes and...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
OBJECTIVE: To validate risk scores to predict occurrence of type 2 diabetes in the Dutch population....
OBJECTIVE: To validate risk scores to predict occurrence of type 2 diabetes in the Dutch population....
Background: The comparative performance of existing models for prediction of type 2 diabetes across ...
Background The comparative performance of existing models for prediction of type 2 diabetes across p...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
BACKGROUND: The World Health Organisation estimates that by 2030 there will be approximately 350 mil...
Aims: to identify all cardiovascular disease risk prediction models developed in patients with type ...
OBJECTIVE: To identify existing prediction models for the risk of development of type 2 diabetes and...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
OBJECTIVE: To validate risk scores to predict occurrence of type 2 diabetes in the Dutch population....
OBJECTIVE: To validate risk scores to predict occurrence of type 2 diabetes in the Dutch population....
Background: The comparative performance of existing models for prediction of type 2 diabetes across ...
Background The comparative performance of existing models for prediction of type 2 diabetes across p...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
BACKGROUND: The World Health Organisation estimates that by 2030 there will be approximately 350 mil...
Aims: to identify all cardiovascular disease risk prediction models developed in patients with type ...